Accurate Measurements of Gastric Emptying and Gastrointestinal Symptoms in the Evaluation of Glucagon-like Peptide-1 Receptor Agonists

Measurement of Gastric Emptying Using a 13C-octanoic Acid Breath Test with Wagner-Nelson Analysis and Scintigraphy in Type 2 Diabetes

(2022) Laurence G Trahair et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Normal and disordered gastric emptying in diabetes: recent insights into (patho)physiology, management and impact on glycaemic control

(2022) Ryan J. Jalleh et al.   DIABETOLOGIA

Semaglutide delays 4‐hour gastric emptying in women with polycystic ovary syndrome and obesity

(2022) Mojca Jensterle et al.   DIABETES OBESITY & METABOLISM

Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic

(2021) Andres Acosta et al.   Obesity

Exenatide once weekly slows gastric emptying of solids and liquids in healthy, overweight people at steady‐state concentrations

(2020) Karen L. Jones et al.   DIABETES OBESITY & METABOLISM

Gastrointestinal Symptoms in Diabetes: Prevalence, Assessment, Pathogenesis, and Management

(2018) Yang T. Du et al.   DIABETES CARE

Comparative Effects of Prolonged and Intermittent Stimulation of the Glucagon-Like Peptide 1 Receptor on Gastric Emptying and Glycemia

(2013) M. M. Umapathysivam et al.   DIABETES

Effect of exenatide on gastric emptying and relationship to postprandial glycemia in type 2 diabetes

(2008) Helle Linnebjerg et al.   REGULATORY PEPTIDES